Concepedia

Author

Itaru Maruyama

Kissei Pharmaceutical (Japan)

Also Known As

I Maruyama, I. Maruyama, Itaru MARUYAMA, Itaru Maruyama

18

Publications

184

Citations

9

H-Index

11

Concepts

All Affiliations

Kissei Pharmaceutical (Japan)
IM

About

Itaru Maruyama is an author at Kissei Pharmaceutical (Japan) specializing in physiology, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

52

2

Pharmacology

3

3

52

3

Physiology

3

3

52

4

Molecular Pharmacology

2

2

38

5

Drug Discovery

1

1

28

Itaru Maruyama

×

8

Publications

150

Citations

8

H-Index

YearCitations

Uroselectivity in male dogs of silodosin (KMD‐3213), a novel drug for the obstructive component of benign prostatic hyperplasia

Satoshi Tatemichi, Yoshitaka Tomiyama, Itaru Maruyama,

Neurourology and Urodynamics

2006

37

Bladder selectivity of the novel β3-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat

Itaru Maruyama, Yoshiaki Goi, Satoshi Tatemichi,

Naunyn-Schmiedeberg s Archives of Pharmacology

2012

28

Effects of Ritobegron (KUC-7483), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function in Cynomolgus Monkey

Itaru Maruyama, Satoshi Tatemichi, Yoshiaki Goi,

Journal of Pharmacology and Experimental Therapeutics

2012

26

Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts

Itaru Maruyama, Yoshitaka Tomiyama, Kazuyasu Maruyama,

European Journal of Pharmacology

2006

14

Comparison of Phosphate Binding Capacities of PA21, A Novel Phosphate Binder, with those of other Phosphate Binders in vitro and in vivo

Atsushi Yaguchi, Saori Yonekubo, Itaru Maruyama,

Drug Research

2016

13

Effects of Silodosin (KMD-3213) on Phenylephrine-induced Increase in Intraurethral Pressure and Blood Pressure in Rats—Study of the Selectivity for Lower Urinary Tract—

Satoshi Tatemichi, Kumi Kobayashi, Itaru Maruyama,

YAKUGAKU ZASSHI

2006

12

Effects of vibegron, a novel β3-adrenoceptor agonist, and its combination with imidafenacin or silodosin in a rat with partial bladder outlet obstruction.

Itaru Maruyama, Shota Yamamoto, Kumi Tsuchioka,

European Journal of Pharmacology

2020

10

Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density

Shota Yamamoto, Hotaka Kusabuka, Akane Matsuzawa,

PLoS ONE

2023

10

Page 1